Figure 3.
PFS and OS (efficacy analysis set). (A) PFS, M+R treatment group. (B) OS, M+R treatment group. (C) PFS, M+R-GemOx treatment group. (D) OS, M+R-GemOx treatment group. NE, not estimable.

PFS and OS (efficacy analysis set). (A) PFS, M+R treatment group. (B) OS, M+R treatment group. (C) PFS, M+R-GemOx treatment group. (D) OS, M+R-GemOx treatment group. NE, not estimable.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal